Home
About
Overview
Sharing Data
ORCID
Help
History (141)
The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organization: when to start, when to stop, which drug to choose, and how to predict response?
Pregnenes
Muramoylpentapeptide Carboxypeptidase
Deferoxamine
Screening for oral premalignancy and cancer: what platform and which biomarkers?
See All 141 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Screening for oral premalignancy and cancer: what platform and which biomarkers?
Screening for oral premalignancy and cancer: what platform and which biomarkers? Cancer Prev Res (Phila). 2010 Sep; 3(9):1056-9.
View in:
PubMed
subject areas
Alphapapillomavirus
Biomarkers, Tumor
Carcinoma, Squamous Cell
Early Detection of Cancer
Humans
Mouth Neoplasms
Precancerous Conditions
Sensitivity and Specificity
authors with profiles
Mark Lingen